Literature DB >> 34665906

Role of nitric oxide in regulating epidermal permeability barrier function.

Mao-Qiang Man1,2, Joan S Wakefield1, Theodora M Mauro1, Peter M Elias1.   

Abstract

Nitric oxide (NO), a free radical molecule synthesized by nitric oxide synthases (NOS), regulates multiple cellular functions in a variety of cell types. These NOS, including endothelial NOS (eNOS), inducible NOS (iNOS) and neural NOS (nNOS), are expressed in keratinocytes. Expression levels of both iNOS and nNOS decrease with ageing, and insufficient NO has been linked to the development of a number of disorders such as diabetes and hypertension, and to the severity of atherosclerosis. Conversely, excessive NO levels can induce cellular oxidative stress, but physiological levels of NO are required to maintain the normal functioning of cells, including keratinocytes. NO also regulates cutaneous functions, including epidermal permeability barrier homeostasis and wound healing, through its stimulation of keratinocyte proliferation, differentiation and lipid metabolism. Topical applications of a diverse group of agents which generate nitric oxide (called NO donors) such as S-nitroso-N-acetyl-D,L-penicillamine (SNAP) can delay permeability barrier recovery in barrier-disrupted skin, but iNOS is still required for epidermal permeability barrier homeostasis. This review summarizes the regulatory role that NO plays in epidermal permeability barrier functions and the underlying mechanisms involved.
© 2021 John Wiley & Sons Ltd. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  differentiation; keratinocyte; nitric oxide; permeability barrier

Mesh:

Substances:

Year:  2021        PMID: 34665906      PMCID: PMC8897205          DOI: 10.1111/exd.14470

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  106 in total

1.  Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis.

Authors:  Do-Won Kim; Jee-Young Park; Gun-Yoen Na; Seok-Jong Lee; Weon-Ju Lee
Journal:  Int J Dermatol       Date:  2006-06       Impact factor: 2.736

2.  Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice.

Authors:  M Mao-Qiang; T Mauro; G Bench; R Warren; P M Elias; K R Feingold
Journal:  Exp Dermatol       Date:  1997-02       Impact factor: 3.960

3.  Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver.

Authors:  Lorenz Schild; Frank Dombrowski; Uwe Lendeckel; Carla Schulz; Andreas Gardemann; Gerburg Keilhoff
Journal:  Biochim Biophys Acta       Date:  2008-01-16

4.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

5.  Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation.

Authors:  J Benrath; M Zimmermann; F Gillardon
Journal:  Neurosci Lett       Date:  1995-11-10       Impact factor: 3.046

6.  Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption.

Authors:  Kazuyuki Ikeyama; Shigeyoshi Fuziwara; Mitsuhiro Denda
Journal:  J Invest Dermatol       Date:  2007-03-15       Impact factor: 8.551

7.  Nitric oxide-mediated apoptosis of neutrophils through caspase-8 and caspase-3-dependent mechanism.

Authors:  Megha Dubey; Sheela Nagarkoti; Deepika Awasthi; Abhishek K Singh; Tulika Chandra; J Kumaravelu; Manoj K Barthwal; Madhu Dikshit
Journal:  Cell Death Dis       Date:  2016-09-01       Impact factor: 8.469

8.  Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo.

Authors:  Mario Vaccaro; Natasha Irrera; Giuseppina Cutroneo; Giuseppina Rizzo; Federico Vaccaro; Giuseppe P Anastasi; Francesco Borgia; Serafinella P Cannavò; Domenica Altavilla; Francesco Squadrito
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

9.  Impaired Healing of a Cutaneous Wound in an Inducible Nitric Oxide Synthase-Knockout Mouse.

Authors:  Takashi Kitano; Hiroshi Yamada; Maki Kida; Yuka Okada; Shizuya Saika; Munehito Yoshida
Journal:  Dermatol Res Pract       Date:  2017-04-13

10.  Genotype-phenotype correlation in two Polish neonates with alveolar capillary dysplasia.

Authors:  Zuzanna Kozłowska; Zuzanna Owsiańska; Joanna P Wroblewska; Apolonia Kałużna; Andrzej Marszałek; Yogen Singh; Bartłomiej Mroziński; Qian Liu; Justyna A Karolak; Paweł Stankiewicz; Gail Deutsch; Marta Szymankiewicz-Bręborowicz; Tomasz Szczapa
Journal:  BMC Pediatr       Date:  2020-06-29       Impact factor: 2.567

View more
  3 in total

1.  Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model.

Authors:  Paula Montero; Javier Milara; Martín Pérez-Leal; Cristina Estornut; Inés Roger; Alejandro Pérez-Fidalgo; Celia Sanz; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

2.  Dracorhodin Perchlorate Regulates the Expression of Inflammatory Cytokines through the TLR4 Pathway and Improves Skin Wound Healing in Diabetic Rats.

Authors:  Zongliang Xiong; Mohan Huo; Yongzhen Jia; Chong Zhou; Xianglin Ma; Hang Yin; Xiaowen Jiang; Wenhui Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

Review 3.  The Immune and Regenerative Response to Burn Injury.

Authors:  Matthew Burgess; Franklin Valdera; David Varon; Esko Kankuri; Kristo Nuutila
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.